Fundraising Fox

Axelyf

Chestnut Hill, US · Founded 2025 · Delaware corporation · 1 known investors

axelyf.com ↗

Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.

AI & Machine LearningBiotechDeep TechHealthtechin /axelyf

Founders & leadership

OA
Orn AlmarssonExecutive Officer, Director, Promoter
AB
Arni BlondalDirector
JL
John LucasDirector

Investors · 1

Brunnur Ventures GP✓ verifiedReykjavik · $1M – $3M

Reported raises · per SEC filings

Form D private placements
▶$4.8MraisedAug 2025 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John LucasDirector
  • Arni BlondalDirector
  • Orn AlmarssonExecutive Officer, Director, Promoter
Offering amount
$6.3M
Amount sold
$4.8M
First sale
Jul 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.